Depletion of anti-gal antibodies in baboons by intravenous therapy with bovine serum albumin conjugated to gal oligosaccharides.
暂无分享,去创建一个
D. Sachs | L. Bühler | D. Cooper | C. Knosalla | M. Awwad | J. Down | B. Gollackner | M. White-Scharf | K. Teranishi | L. Correa
[1] D. Sachs,et al. COAGULATION AND THROMBOTIC DISORDERS ASSOCIATED WITH PIG ORGAN AND HEMATOPOIETIC CELL TRANSPLANTATION IN NONHUMAN PRIMATES , 2000, Transplantation.
[2] D. Sachs,et al. Plasma perfusion by apheresis through a Gal immunoaffinity column successfully depletes anti‐Gal antibody: experience with 320 aphereses in baboons , 2000, Xenotransplantation.
[3] D. Sachs,et al. High-dose porcine hematopoietic cell transplantation combined with CD40 ligand blockade in baboons prevents an induced anti-pig humoral response. , 2000, Transplantation.
[4] F. Waxman,et al. Glomerular Deposition of Immune Complexes Made with IgG2a Monoclonal Antibodies1 , 2000, The Journal of Immunology.
[5] D. Sachs,et al. Peripheral blood progenitor cell mobilization and leukapheresis in pigs. , 1999, Laboratory animal science.
[6] A Nardin,et al. How are immune complexes bound to the primate erythrocyte complement receptor transferred to acceptor phagocytic cells? , 1999, Molecular immunology.
[7] D. Cooper,et al. The problem of anti‐pig antibodies in pig‐to‐primate xenografting: current and novel methods of depletion and/or suppression of production of anti‐pig antibodies , 1999, Xenotransplantation.
[8] D. Sachs,et al. Transfer of swine major histocompatibility complex class II genes into autologous bone marrow cells of baboons for the induction of tolerance across xenogeneic barriers. , 1999, Transplantation.
[9] R. Colvin,et al. Porcine kidney and heart transplantation in baboons undergoing a tolerance induction regimen and antibody adsorption. , 1999, Transplantation.
[10] L. Svensson,et al. Intravenous synthetic αgal saccharides delay hyperacute rejection following pig‐to‐baboon heart transplantation , 1999, Xenotransplantation.
[11] R. Colvin,et al. Disseminated intravascular coagulation in association with the delayed rejection of pig-to-baboon renal xenografts. , 1998, Transplantation.
[12] D. Sachs,et al. Pharmacologic immunosuppressive therapy and extracorporeal immunoadsorption in the suppression of anti‐αGal antibody in the baboon , 1998, Xenotransplantation.
[13] D. Sachs,et al. Discordant organ xenotransplantation in primates: world experience and current status. , 1998, Transplantation.
[14] W. Mckane,et al. Polymorphism in the human anti-pig natural antibody repertoire: implications for antigen-specific immunoadsorption. , 1998, Transplantation.
[15] D. Sachs,et al. Anti-Gal(alpha)1-3Gal antibody response to porcine bone marrow in unmodified baboons and baboons conditioned for tolerance induction. , 1998, Transplantation.
[16] D. Sachs,et al. Depletion of anti‐Galα1–3Gal antibody in baboons by specific α‐Gal immunoaffinity columns , 1998 .
[17] D. Zopf,et al. Intravenous infusion of Galalpha1-3Gal oligosaccharides in baboons delays hyperacute rejection of porcine heart xenografts. , 1998, Transplantation.
[18] T. Sablinski,et al. Removal of anti-porcine natural antibodies from human and nonhuman primate plasma in vitro and in vivo by a Galalpha1-3Galbeta1-4betaGlc-X immunoaffinity column. , 1998, Transplantation.
[19] A. Rose,et al. Delayed xenograft rejection of pig-to-baboon cardiac transplants after cobra venom factor therapy. , 1997, Transplantation.
[20] D. Sachs,et al. Heterogeneity of human anti-pig natural antibodies cross-reactive with the Gal(alpha1,3)Galactose epitope. , 1997, Transplantation.
[21] R. Hawley,et al. Xenogeneic bone marrow transplantation: II. Porcine‐specific growth factors enhance porcine bone marrow engraftment in an in vitro primate microenvironment , 1997 .
[22] M. Denaro,et al. Xenogeneic bone marrow transplantation: I. Cloning, expression, and species specificity of porcine IL‐3 and granulocyte‐macrophage colony‐stimulating factor , 1997 .
[23] E. Korchagina,et al. In vivo immunoadsorption of antipig antibodies in baboons using a specific Gal(alpha)1-3Gal column. , 1996, Transplantation.
[24] D. Cooper,et al. Monoclonal antiidiotypic antibodies neutralize cytotoxic effects of anti-alphaGal antibodies. , 1996, Transplantation.
[25] J. Platt,et al. Specificity of xenoreactive anti-Galα1–3Gal IgM for α-galactosyl ligands , 1996 .
[26] R. Nilsson,et al. Polymorphism within the human anti-pig repertoire. , 1996, Transplantation proceedings.
[27] R. Oriol,et al. The reducing end of αGal oligosaccharides contributes to their efficiency in blocking natural antibodies of human and baboon sera , 1996, Transplant international : official journal of the European Society for Organ Transplantation.
[28] B. Benson,et al. Human IgM xenoreactive natural antibodies can induce resistance of porcine endothelial cells to complement‐mediated injury , 1996 .
[29] M. Walport,et al. Clearance pathways of soluble immune complexes in the pig. Insights into the adaptive nature of antigen clearance in humans. , 1995, Journal of immunology.
[30] R. Oriol,et al. Evidence that intravenously administered alpha-galactosyl carbohydrates reduce baboon serum cytotoxicity to pig kidney cells (PK15) and transplanted pig hearts. , 1994, Transplantation.
[31] M. Sandrin,et al. Anti-pig IgM antibodies in human serum react predominantly with Gal(alpha 1-3)Gal epitopes. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[32] R. Oriol,et al. SPECIFIC INTRAVENOUS CARBOHYDRATE THERAPY A NEW CONCEPT IN INHIBITING ANTIBODY‐MEDIATED REJECTION—EXPERIENCE WITH ABO‐INCOMPATIBLE CARDIAC ALLOGRAFTING IN THE BABOON , 1993, Transplantation.
[33] U. Galili. Interaction of the natural anti-Gal antibody with alpha-galactosyl epitopes: a major obstacle for xenotransplantation in humans. , 1993, Immunology today.
[34] R. Oriol,et al. Identification of alpha-galactosyl and other carbohydrate epitopes that are bound by human anti-pig antibodies: relevance to discordant xenografting in man. , 1993, Transplant immunology.
[35] D. Cooper. Depletion of natural antibodies in non-human primates--a step towards successful discordant xenografting in humans. , 1992, Clinical transplantation.
[36] D. Cooper,et al. Heterogeneity of preformed human antipig xenogeneic antibodies. , 1992, Transplantation proceedings.
[37] D. Cooper,et al. Identification of carbohydrate structures that bind human antiporcine antibodies: implications for discordant xenografting in humans. , 1992, Transplantation proceedings.
[38] M. Walport,et al. A study of in vivo immune complex formation and clearance in man. , 1990, Journal of immunology.
[39] B. Linn,et al. Renal xenograft prolongation by suppression of natural antibody. , 1968, The Journal of surgical research.
[40] J. Najarian,et al. EXPERIMENTAL RENAL HETEROTRANSPLANTATION: I. In Widely Divergent Species , 1966, Transplantation.